Aurobindo Pharma Ltd - ESG Rating & Company Profile powered by AI
The ESG assessment for Aurobindo Pharma Ltd represents its transparency towards the United Nations Sustainable Development Goals. If you work at Aurobindo Pharma Ltd and you would like to licence your ESG rating, please get in touch. The assessment of Aurobindo Pharma Ltd employs data points from across the web and also from public filings by Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Novartis AG | 9.2 | High |
2 | Daiichi Sankyo Co Ltd | 8.9 | High |
18 | Pacific Biosciences of California Inc | 8.2 | High |
18 | Valneva SE | 8.2 | High |
36 | Aurobindo Pharma Ltd | 8.1 | High |
36 | Adcock Ingram Holdings Ltd | 8.1 | High |
36 | Alkem Laboratories Ltd | 8.1 | High |
... | ... | ... | |
2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
2749 | Zyden Gentec Ltd | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Aurobindo Pharma Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Aurobindo Pharma Ltd report the average age of the workforce?
Sign up for free to unlockDoes Aurobindo Pharma Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Aurobindo Pharma Ltd offer flexible work?
Sign up for free to unlockDoes Aurobindo Pharma Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aurobindo Pharma Ltd conduct supply chain audits?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aurobindo Pharma Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose water use targets?
Sign up for free to unlockDoes Aurobindo Pharma Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Aurobindo Pharma Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Aurobindo Pharma Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aurobindo Pharma Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aurobindo Pharma Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aurobindo Pharma Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aurobindo Pharma Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose its waste policy?
Sign up for free to unlockDoes Aurobindo Pharma Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose energy use targets?
Sign up for free to unlockDoes Aurobindo Pharma Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aurobindo Pharma Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aurobindo Pharma Ltd
These potential risks are based on the size, segment and geographies of the company.
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.